Ngā Pūrongo me ngā Pānuitanga

Reports and Publications

Stay up to date with our latest publications and reports.

On this page you'll find links to the Agency's Annual Reports; Briefings to the Incoming Minister; Guidance for the sector, publications and reports, and Requests for Proposal.

Annual Reports

These reports provide an overview of the milestones and achievements of Te Aho o Te Kahu each year.

2022/23

Te Aho o Te Kahu Annual Report 2022/23 (Word 3MB)

Te Aho o Te Kahu Annual Report 2022/23 (PDF 3 MB)

2021/22

Te Aho o Te Kahu Annual Report 2021/22 (Word 400KB)

Te Aho o Te Kahu Annual Report 2021/22 (PDF 1 MB)

2020/21

Te Aho o Te Kahu Annual Report 2020/21 (Word 308KB)

Te Aho o Te Kahu Annual Report 2020/21 (PDF 6MB)

2019/20

Te Aho o Te Kahu Annual Report 2019/20 (Word 3468 KB)

Te Aho o Te Kahu Annual Report 2019/20 (PDF 816 KB)

Briefings to the Incoming Minister (BIMs)

We provide Briefings to Incoming Ministers (BIMs) following a general election or where there is change in minister. They outline our role, work and key priorities, challenges and strategic opportunities.

Some information may have been withheld under the Official Information Act 1982. Where information has been withheld that is indicated within the document.

Te Aho o Te Kahu BIM February 2024 (PDF 3MB)

Te Aho o Te Kahu BIM March 2023 (PDF 2.5MB)

Te Aho o Te Kahu BIM November 2020 (PDF 7MB)

Reports

He Mahere Ratonga Mate Pukupuku - Cancer Services Planning Report July 2022 provides a summary of the current issues in adult cancer treatment services in Aotearoa New Zealand and sets out key focus areas to improve cancer treatment. It proposes a direction of travel which can be considered by decision-makers and service providers as they design and implement a reformed health system.

Mārama ana ki te Āputa: he tātari i te wāteatanga o ngā rongoā mate pukupuku i Aotearoa | Understanding the Gap: an analysis of the availability of cancer medicines in Aotearoa.. This report analyses what cancer medicines for solid tumours are funded in Australia compared to New Zealand – both in quantity and clinical benefit. This analysis was developed in response to questions on this from across the sector and people and whānau living with cancer. We are carrying out similar comparison analysis on blood cancer medicines which we expect will be completed towards late June-July 2024.

He Pūrongo Mate Pukupuku o Aotearoa 2020, The State of Cancer in New Zealand 2020 provides a summary of the available data on our country’s system of cancer prevention and care. It also highlights gaps in our knowledge and areas where more research and attention could be focused.

Pūrongo Ārai Mate Pukupuku, the Cancer Prevention Report. Cancer is the leading cause of health loss in Aotearoa New Zealand with about 25,000 people diagnosed every year. Cancer is a complex condition, and it is not possible to predict who will develop cancer and who will not. However, half of all cancers are potentially preventable by reducing everyone’s exposure to the cancer risk factors present in our environments. This report focuses on what actions Aotearoa can take to stop cancers developing whenever possible.

Route to diagnosis: People diagnosed with cancer within 30-days of an emergency or acute (unplanned) hospital admission. As part of our monitoring and Quality Improvement Programme we have released a report looking into the number of people diagnosed with cancer within 30-days of an emergency or acute (unplanned) hospital admission by districts around the motu | country.

Guidance

Quality Statements to Guide Melanoma Diagnosis and Care in New Zealand - developed by the National Melanoma Working Group (NMWG) and MelNet

These statements describe what quality care for melanoma should look like in Aotearoa | New Zealand based on current global best practice and will inform efforts to reduce the incidence and improve outcomes for melanoma patients and their families.

The statements were developed in partnership with a wide range of sector experts and key stakeholders, including Te Aho o Te Kahu. We acknowledge the Quality Statements to Guide Melanoma Diagnosis and Care in New Zealand and support their use as a tool to guide clinical decision-making and promote best practice melanoma management in Aotearoa | New Zealand. We played a key role in completing the first edition and remained involved on subsequent editions.

To read the Quality Statements to Guide Melanoma Diagnosis and Care in New Zealand please visit the MelNet website www.melnet.org.nz

Standards for high-quality cancer Multidisciplinary Meetings (MDMs) in Aotearoa New Zealand - March 2024

Multidisciplinary Meetings (MDMs) are an important component of quality cancer care. These meetings are where health professionals review and discuss all the clinical, psychosocial, and cultural information about a patient, and recommend personalised treatment and care options based on the person's needs and best practice cancer treatment pathways.

Effective meetings will help improve the quality of cancer care people receive and their health outcomes, including some the benefits listed below:

  • improved treatment planning as health professionals consider the full range of therapeutic options available
  • reduce health inequities experienced by Māori, Pacific peoples, people living rurally and other priority patients using a person-centred framework
  • improved communication between care providers as clear lines of responsibility are developed between members of the MDM
  • improved service coordination
  • greater continuity of care and less duplication of services
  • more patients being offered the opportunity to take part in relevant clinical trials
  • enabling clinicians to share and discuss latest evidence and/or approaches to increase skills and knowledge.

The standards reset the direction of MDMs in Aotearoa and provide detailed best practice requirements for MDM governance, resourcing, processes and data. The information can be used by a range of individuals / organisations to improve the efficiency and quality of MDMs, including:

  • Health professionals who run and/or participate in MDMs
  • Health New Zealand Te Whatu Ora hospital and health service operational leads who are responsible for ensuring that individual MDMs are supported and managed appropriately
  • National organisations involved in cancer service commissioning and monitoring, and those developing models of care, including Health New Zealand and Te Aho o Te Kahu.

This is an internal guidance document for the sector.

Standards for high-quality cancer Multidisciplinary Meetings (MDMs) in Aotearoa New Zealand (PDF, 767KB)

Standards for high-quality cancer Multidisciplinary Meetings (MDMs) in Aotearoa New Zealand (WORD 349KB)

Update on Polyp Surveillance Guidelines 2020

This document is based on current available evidence for surveillance after a colonoscopy and complete removal of adenomas and serrated polyps. This advice aligns with recent publications from the United Kingdom, United States, Australia and Europe.

Ministry of Health Cancer Publications

New Zealand Cancer Action Plan

Our New Zealand Cancer Action Plan 2019-2029 provides a pathway to improve cancer outcomes for all New Zealanders.

Cancer Control Strategy

The New Zealand Cancer Control Strategy provides the overall direction for cancer related activities to help reduce the incidence and impact of cancer and reduce inequalities with respect to cancer.

Requests for Proposals

Early in 2021 the Health Research Council, Ministry of Health and Te Aho o Te Kahu released a Request for Proposals (RFP) to fund research that responds to one or more equity-centred cancer research priorities:

  • Lung cancer screening
  • Lung cancer research of any discipline
  • Patient experience across the cancer journey for Māori and Pacific
  • Innovative approaches to delivering cancer care.

All the details are available here.